Table 5:
Univariable analysis |
Multivariable analysis |
|||||
---|---|---|---|---|---|---|
Variable | Odds ratio | 95% CI | P-value | Odds ratio | 95% CI | P-value |
non-BPA group (vs BPA group) | 10.83 | 1.30, 90.14 | 0.028 | 7.52 | 0.86, 65.49 | 0.068 |
Age (years) | 0.98 | 0.93, 1.03 | 0.386 | |||
Female | 1.03 | 0.29, 3.60 | 0.965 | |||
NYHA/WHO functional class III, IV (vs II) | 1.90 | 0.46, 7.85 | 0.377 | |||
mPAP (mmHg) | 1.14 | 1.00, 1.29 | 0.047 | 1.10 | 0.95, 1.26 | 0.191 |
Current smoker | 0.49 | 0.05, 4.44 | 0.523 | |||
Former smoker | 0.65 | 0.16, 2.72 | 0.556 | |||
Thrombotic predisposition | 1.23 | 0.28, 5.44 | 0.787 | |||
Hypertension | 1.59 | 0.47, 5.33 | 0.454 | |||
Dyslipidaemia | 0.75 | 0.14, 4.03 | 0.737 | |||
History of symptomatic cerebral infarction | 5.73 | 0.85, 38.61 | 0.073 | |||
Without oral PAH-targeted medical treatment | 0.49 | 0.05, 4.44 | 0.523 | |||
Surgical classification III, IV (vs I, II) | 3.73 | 0.66, 21.09 | 0.137 | |||
Concomitant surgery | 2.16 | 0.58, 8.05 | 0.251 |
Concomitant surgery comprises patients with tricuspid annuloplasty, the maze procedure, coronary artery bypass grafting, mitral valve repair, surgical aortic valve replacement or ascending aortic replacement.
BPA: balloon pulmonary angioplasty; CI: confidence interval; mPAP: mean pulmonary arterial pressure; NYHA/WHO: New York Heart Association/World Health Organization; PAH: pulmonary arterial hypertension.